The domain within your query sequence starts at position 38 and ends at position 104; the E-value for the PTPA domain shown below is 5.7e-28.
KWKRSQMKTGPFAEHSNQLWNISAVPSWSKVNQGLIRMYKAECLEKFPVIQHFKFGSLLP IHPVTSG
PTPA |
 |
|---|
| PFAM accession number: | PF03095 |
|---|---|
| Interpro abstract (IPR004327): | Phosphotyrosyl phosphatase activator (PTPA, also known as protein phosphatase 2A activator) proteins stimulate the phosphotyrosyl phosphatase (PTPase) activity of the dimeric form of protein phosphatase 2A (PP2A). PTPase activity in PP2A (in vitro) is relatively low when compared to the better recognised phosphoserine/ threonine protein phosphorylase activity. It also reactivates the serine/threonine phosphatase activity of an inactive form of PP2A. The specific biological role of PTPA is unknown. PTPA has been suggested to play a role in the insertion of metals to the PP2A catalytic subunit (PP2Ac) active site, to act as a chaperone, and more recently, to have peptidyl prolyl cis/trans isomerase activity that specifically targets human PP2Ac [ (PUBMED:16885030) (PUBMED:16916641) (PUBMED:16782712) (PUBMED:16380387) (PUBMED:15447631) (PUBMED:12952889) ]. Together, PTPA and PP2A constitute an ATPase and it has been suggested that PTPA alters the relative specificity of PP2A from phosphoserine/phosphothreonine substrates to phosphotyrosine substrates in an ATP-hydrolysis-dependent manner. Basal expression of PTPA depends on the activity of a ubiquitous transcription factor, Yin Yang 1 (YY1). The tumour suppressor protein p53 can inhibit PTPA expression through an unknown mechanism that negatively controls YY1 [ (PUBMED:11171037) ]. |
| GO function: | phosphatase activator activity (GO:0019211) |
This is a PFAM domain. For full annotation and more information, please see the PFAM entry PTPA